Shenzhen - Delayed Quote CNY

Zhejiang Wecome Pharmaceutical Company Limited (300878.SZ)

16.86 -0.50 (-2.88%)
At close: April 26 at 3:04 PM GMT+8
Key Events
Advanced Chart
Loading Chart for 300878.SZ
DELL
  • Previous Close 17.36
  • Open 17.10
  • Bid 16.86 x --
  • Ask 16.87 x --
  • Day's Range 16.80 - 17.37
  • 52 Week Range 13.73 - 38.23
  • Volume 2,461,080
  • Avg. Volume 2,568,379
  • Market Cap (intraday) 2.441B
  • Beta (5Y Monthly) 0.12
  • PE Ratio (TTM) 120.43
  • EPS (TTM) 0.14
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date Jun 17, 2022
  • 1y Target Est --

Zhejiang Wecome Pharmaceutical Company Limited engages in the research and development, production, and sale of modern traditional Chinese and western medicine in China. The company offers products in various forms, including hard capsules, tablets, granules, soft capsules, pills, and other dosage forms. It also operates distribution business, such as retail chains. The company was formerly known as Zhejiang Weikang Pharmaceutical Co., Ltd. Zhejiang Wecome Pharmaceutical Company Limited was founded in 2000 and is based in Lishui, China.

www.zjwk.com

1,082

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Biotechnology

Industry

More about Zhejiang Wecome Pharmaceutical Company Limited

Related News

View More
View More

Performance Overview: 300878.SZ

Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

300878.SZ
33.54%
SSE Composite Index
3.82%

1-Year Return

300878.SZ
24.60%
SSE Composite Index
5.40%

3-Year Return

300878.SZ
36.11%
SSE Composite Index
11.10%

5-Year Return

300878.SZ
--
SSE Composite Index
8.77%

Compare To: 300878.SZ

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

300878.SZ
Zhejiang Wecome Pharmaceutical Company Limited
16.86
-2.88%
Mkt Cap CNY 2.441B
Industry Biotechnology
6547.TWO
Medigen Vaccine Biologics Corporation
51.30
-1.35%
Mkt Cap TWD 16.858B
Industry Biotechnology

Statistics: 300878.SZ

View More

Valuation Measures

Annual
As of 4/26/2024

  • Market Cap

    2.44B

  • Enterprise Value

    2.44B

  • Trailing P/E

    120.17

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    4.94

  • Price/Book (mrq)

    1.66

  • Enterprise Value/Revenue

    4.98

  • Enterprise Value/EBITDA

    63.53

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    4.06%

  • Return on Assets (ttm)

    0.13%

  • Return on Equity (ttm)

    1.45%

  • Revenue (ttm)

    488.94M

  • Net Income Avi to Common (ttm)

    19.86M

  • Diluted EPS (ttm)

    0.14

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    436.81M

  • Total Debt/Equity (mrq)

    29.05%

  • Levered Free Cash Flow (ttm)

    -79.08M

View More

Company Insights: 300878.SZ

People Also Watch

300404.SZ Boji Medical Technology Co.,Ltd.
7.31
+0.55%
 
688513.SS Chengdu Easton Biopharmaceuticals Co., Ltd.
57.64
-3.17%
 
300049.SZ Inner Mongolia Furui Medical Science Co., Ltd.
51.50
+3.56%
 
300653.SZ Yantai Zhenghai Biotechnology Co., Ltd.
23.85
+2.27%
 
300294.SZ China Resources Boya Bio-pharmaceutical Group Co.,Ltd
31.28
+0.68%
 
300858.SZ Beijing Scitop Bio-tech Co., Ltd.
15.55
+0.78%
 
300381.SZ Guangdong VTR Bio-Tech Co., Ltd.
5.41
+9.07%
 
603439.SS Guizhou Sanli Pharmaceutical Co.,Ltd
15.43
+0.78%
 
300705.SZ Hunan Jiudian Pharmaceutical Co., Ltd.
36.22
+3.46%
 
688488.SS Jiangsu Aidea Pharmaceutical Co., Ltd.
15.54
-1.58%
 
300181.SZ Zhejiang Jolly Pharmaceutical Co.,LTD
14.22
-2.20%
 
688266.SS Suzhou Zelgen Biopharmaceuticals Co.,Ltd.
53.40
+4.38%
 
300841.SZ Chengdu Kanghua Biological Products Co., Ltd.
60.80
+2.01%
 
300497.SZ Jiangxi Fushine Pharmaceutical Co., Ltd.
9.50
+5.32%
 
688222.SS HitGen Inc.
12.98
+3.02%
 
300147.SZ Xiangxue Pharmaceutical Co.,Ltd.
3.6100
-0.28%